MSL
CVET

Mackay Shields LLC’s Covetrus, Inc. Common Stock CVET Stock Holding History

Mackay Shields LLC’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-167,900
Closed -$4.1M – 1626
2020
Q3 		$4.1M Buy
+167,900
New +$3.62M 0.03% 493

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
FCM
Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return

Mackay Shields LLC's CVET Position: Q4 2020 in Review

Mackay Shields LLC sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2020, closing a stake of 167,900 shares — an estimated $4.1M sold.

Mackay Shields LLC first reported a position in CVET in Q3 2020 and held it in 1 quarter. The position peaked at $4.1M in Q3 2020. 277 funds tracked by Wall St. Rank hold CVET as of Q4 2020.

  • Mackay Shields LLC reported no remaining Covetrus, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Mackay Shields LLC sold 167,900 Covetrus, Inc. Common Stock shares in Q4 2020, an estimated $4.1M.
  • Mackay Shields LLC first reported a position in Covetrus, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Mackay Shields LLC's Covetrus, Inc. Common Stock position peaked at $4.1M in Q3 2020.
  • 277 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2020.

Based on Mackay Shields LLC's 13F filing for Q4 2020, filed 16 Feb 2021.